SEC Form 4 · accession 0001209191-19-000884
HARVARD BIOSCIENCE INC · HBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kamalam Unninayar
Officer — Chief Financial Officer
Period of report
Jan 1, 2019
Accepted (ET)
Jan 3, 2019 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001123494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 1, 2019 | F | 1,603 | $3.18 | D | 16,866 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with deferred stock awards previously granted to the Reporting Person which vested in part on January 1, 2019.
- F2Includes (a) a deferred stock award of 13,852 restricted stock units which vest in three equal annual installments on January 1, 2020, 2021 and 2022; and (b) 3,014 shares of common stock held by the Reporting Person.
Remarks
The form is signed under power of attorney.